BRIDGEWATER, N.J., July 31, 2019 – Bausch + Lomb, a leading global eye health company, today announced that it has initiated the first in a series of U.S. clinical trials to evaluate the safety and efficacy of the Technolas® Teneo™ excimer laser for vision correction surgery for myopia and myopic astigmatism.
“This is an exciting milestone for our organization, as it’s the first step on the road to filing for regulatory approval for the Teneo laser in the United States,” said Chuck Hess, vice president and general manager, U.S. Surgical, Bausch + Lomb. “Teneo has been well received and widely adopted in more than 50 markets globally as one of the most versatile lasers on the market with the added benefit of a compact footprint, and we look forward to bringing this technology to surgeons and their patients in the United States, as well.”
This pivotal clinical trial is a multicenter, prospective, open label, non-randomized study being conducted in the United States, evaluating the effectiveness of the Technolas Teneo 317 (model 2) excimer laser in LASIK surgery for myopia or myopic astigmatism. Participants in the study will undergo safety and efficacy evaluation at the time when refractive stability has been achieved (study endpoint).
About Bausch + Lomb
Bausch + Lomb, a wholly owned subsidiary of Bausch Health Companies Inc., is a leading global eye health organization that is solely focused on helping people see better to live better. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries. For more information, visit www.bausch.com.
®/TM are trademarks of Bausch & Lomb Incorporated or its affiliates.
All other product/brand names are trademarks of the respective owners.
© 2019 Bausch & Lomb Incorporated or its affiliates.
The website you are about to visit is not affiliated with Bausch + Lomb Incorporated. Bausch + Lomb is not responsible for the content, format, maintenance, or policies of the website you are about to enter and does not monitor non-affiliated websites for accuracy. Links to non-affiliated websites are provided as a convenience; they do not constitute an endorsement or support of any programs, products, or services associated with the website.